Alaska Native and American Indian adults have a high prevalence of AAV, with distinct clinical characteristics and treatment patterns observed.

A total of 209 patients received upadacitinib at a dose of 15 mg, 107 received upadacitinib at a dose of 7.5 mg, and 112 received placebo; 70% of the patients had new-onset giant-cell arteritis ...

Emactuzumab has received fast track designation from the U.S. FDA for patients with tenosynovial giant cell tumors and who would not benefit from surgery. Treatment with emactuzumab has received fast ...

AbbVie ABBV announced that the European Commission has granted marketing approval to its blockbuster drug Rinvoq for treating giant cell arteritis (“GCA”), an autoimmune disease that causes ...

RINVOQ is the first and only oral Janus kinase (JAK) inhibitor approved in the European Union (EU) to treat adult patients with giant cell arteritis (GCA) The approval is supported by data from ...

[5] Bruits may be heard over the carotid or subclavian areas, or rarely over the orbits. Giant cell arteritis is a systemic vasculitis and careful attention should be given to the examination of ...

Plume, a blockchain platform focused on real-world assets (RWAs), said on Tuesday it secured an investment from funds managed by private equity giant Apollo Global Management as it looks to scale ...

Macquarie, the Australian financial giant, has struck its latest British takeover deal with a swoop on Metcor Group, a provider of drainage and maintenance services to commercial customers.